Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System

Historical context for JNJ

Across the 22 sessions after earlier JNJ headlines, the stock closed higher 10 times and lower 12 times, with a median move of 1.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.